CHMP Backs Antiarrhythmic for Muscle-Contraction Disorders CHMP Backs Antiarrhythmic for Muscle-Contraction Disorders

The EMA committee has recommended marketing authorization for the first treatment for adults with nondystrophic myotonia, a group of rare muscle contraction disorders characterized by pain and fatigue.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news